| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Research and development | $794.3M+66.6% | $476.6M+43.4% | $332.3M+96.1% | $169.5M+116.1% | $78.4M+6.6% | $73.6M+61.3% | $45.6M |
| Acquired manufacturing rights | $0 | $0-100.0% | $75.0M+226.2% | $23.0M | — | — | — |
| General and administrative | $129.4M+39.3% | $92.9M+53.1% | $60.7M+52.5% | $39.8M+57.6% | $25.3M+57.7% | $16.0M+87.4% | $8.5M |
| Total operating expenses | $923.7M+62.2% | $569.5M+21.7% | $468.0M+101.5% | $232.3M+124.0% | $103.7M+15.7% | $89.6M+65.4% | $54.2M |
| Loss from operations | -$923.7M-62.2% | -$569.5M-21.7% | -$468.0M-101.5% | -$232.3M-124.0% | -$103.7M-15.7% | -$89.6M-65.4% | -$54.2M |
| Interest income | $119.7M+8.8% | $110.0M+74.9% | $62.9M+652.8% | $8.4M+2329.1% | $344K+41.0% | $244K-61.4% | $632K |
| Other income (expense) | $37.3M+953.2% | -$4.4M-252.5% | $2.9M+587.8% | $417K-88.4% | $3.6M+887.1% | $364K-90.6% | $3.9M |
| Total other income, net | $157.0M+48.7% | $105.6M+60.6% | $65.8M+649.9% | $8.8M+144.1% | $3.6M | — | — |
| Net loss | -$766.6M-65.2% | -$463.9M-15.3% | -$402.3M-80.0% | -$223.5M-123.3% | -$100.1M-12.2% | -$89.2M-77.5% | -$50.3M |
| Net loss per share, basic (in dollars per share) | -$5630.00-48.2% | -$3800.00+8.2% | -$4140.00-20.3% | -$3440.00-78.2% | -$1930.00+36.1% | -$3020.00 | — |
| Net loss per share, diluted (in dollars per share) | -$5630.00-48.2% | -$3800.00+8.2% | -$4140.00-20.3% | -$3440.00-78.2% | -$1930.00+36.1% | -$3020.00 | — |
| Weighted-average shares outstanding, basic (in shares) | 136.09B+11.6% | 122.00B+25.6% | 97.16B+49.8% | 64.88B+25.0% | 51.92B+75.7% | 29.55B | — |
| Weighted-average shares outstanding, diluted (in shares) | 136.09B+11.6% | 122.00B+25.6% | 97.16B+49.8% | 64.88B+25.0% | 51.92B+75.7% | 29.55B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.